Reactive Oxygen and Nitrogen Species Release of Single Pancreatic Cancer Cells Subjected to Pulsed Electric Field Ablation: Concentration and Dynamics.
기술보고
1/5 보강
ℹ️ 이 논문은 무료 전문이 아직 없습니다. 코퍼스 전체의 43.7%는 무료 가능 (통계 →) · 🏥 기관 EZproxy로 시도
Pancreatic cancer, recognized for its extreme lethality, is normally diagnosed at an advanced stage, leaving only a minority of patients eligible for surgical resection.
APA
Ye Z, Zhao Y, et al. (2025). Reactive Oxygen and Nitrogen Species Release of Single Pancreatic Cancer Cells Subjected to Pulsed Electric Field Ablation: Concentration and Dynamics.. Analytical chemistry, 97(30), 16194-16202. https://doi.org/10.1021/acs.analchem.5c00990
MLA
Ye Z, et al.. "Reactive Oxygen and Nitrogen Species Release of Single Pancreatic Cancer Cells Subjected to Pulsed Electric Field Ablation: Concentration and Dynamics.." Analytical chemistry, vol. 97, no. 30, 2025, pp. 16194-16202.
PMID
40695737 ↗
Abstract 한글 요약
Pancreatic cancer, recognized for its extreme lethality, is normally diagnosed at an advanced stage, leaving only a minority of patients eligible for surgical resection. Pulsed electric field (PEF) ablation, an ablative technique for clinical treatment of locally advanced pancreatic cancer, causes tumor cell death by disrupting cellular redox balance, resulting in the overproduction of reactive oxygen species (ROS) and reactive nitrogen species (RNS). In situ monitoring of the dynamic changes in ROS/RNS levels of pancreatic cancer cells under PEF ablation is important for understanding its mechanism for pancreatic cancer treatment. Here, we constructed an in vitro pancreatic cancer cell model via culturing PANC-1 cells on polyacrylamide gels with a stiffness of 4.0 kPa to simulate the mechanical microenvironment of advanced pancreatic cancer stage. We then established a theoretical model and simulated the electric field strengths of PEF ablation used for the clinical treatment of pancreatic cancer. After applying PEF ablation with these electric field strengths on the in vitro pancreatic cancer cell model, we in situ monitored the dynamic releasing processes of hydrogen peroxide (HO) and nitric oxide (NO) from PANC-1 cells by employing scanning electrochemical microscopy (SECM). Through quantitative analysis of SECM results, we found that the electric field strengths of PEF ablation over 1.5 kV cm caused cells to exhibit periodic bursts of HO and NO effluxes during the initial 5 min and then reduced to their initial values within 6 min after treatment, while mitochondrial dysfunction persisted. It demonstrates a prolonged impact of electric field strength on disrupting cellular redox balance, offering valuable insights into the mechanism of electric field strength-dependent redox imbalance of pancreatic cancer under electric ablation.
🏷️ 키워드 / MeSH 📖 같은 키워드 OA만
같은 제1저자의 인용 많은 논문 (5)
- Decoding the mitochondrial metabolic engine for tumor metastasis and clinical therapeutic opportunities.
- Single-Cell Transcriptomic Landscape of Right-Sided Colon Cancer Reveals Cellular and Molecular Features of Metastatic Potential.
- Nanomedicine strategies for disulfidptosis activation in SLC7A11-high tumors.
- Genome-wide analysis highlights epigenetic link to age at menarche.
- HAMIL: Hierarchical Attention Multi-Instance Learning for Label-Free Colorectal Cancer Typing.
🏷️ 같은 키워드 · 무료전문 — 이 논문 MeSH/keyword 기반
- A Phase I Study of Hydroxychloroquine and Suba-Itraconazole in Men with Biochemical Relapse of Prostate Cancer (HITMAN-PC): Dose Escalation Results.
- Self-management of male urinary symptoms: qualitative findings from a primary care trial.
- Clinical and Liquid Biomarkers of 20-Year Prostate Cancer Risk in Men Aged 45 to 70 Years.
- Diagnostic accuracy of Ga-PSMA PET/CT versus multiparametric MRI for preoperative pelvic invasion in the patients with prostate cancer.
- Association of patient health education with the postoperative health related quality of life in low- intermediate recurrence risk differentiated thyroid cancer patients.
- Early local immune activation following intra-operative radiotherapy in human breast tissue.